Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with transient elastography-defined subclinical cirrhosis.
about
Imaging Based Methods of Liver Fibrosis Assessment in Viral Hepatitis: A Practical ApproachUse of Wisteria Floribunda Agglutinin-Positive Human Mac-2 Binding Protein in Assessing Risk of Hepatocellular Carcinoma Due to Hepatitis B VirusLiver fibrosis regression and progression during controlled hepatitis B virus infection among HIV-HBV patients treated with tenofovir disoproxil fumarate in France: a prospective cohort study.Histological outcome for chronic hepatitis B patients treated with entecavir vs lamivudine-based therapy.Transient Elastography is Superior to FIB-4 in Assessing the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis BRisk Assessment of Hepatocellular Carcinoma Using Transient Elastography Vs. Liver Biopsy in Chronic Hepatitis B Patients Receiving Antiviral Therapy.Non-invasive assessment of liver fibrosis and prognosis.Association between complicated liver cirrhosis and the risk of hepatocellular carcinoma in Taiwan.Liver cirrhosis stages and the incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving antiviral therapy.Fibrosis assessment: impact on current management of chronic liver disease and application of quantitative invasive tools.Role of Shear Wave Elastography in Evaluating the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B.Subcirrhotic liver stiffness by FibroScan correlates with lower risk of hepatocellular carcinoma in patients with HBV-related cirrhosis.Non-invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low-level viremia.Improvement of Liver Fibrosis after Long-Term Antiviral Therapy Assessed by Fibroscan in Chronic Hepatitis B Patients With Advanced Fibrosis.Durability of the virological response after lamivudine discontinuation in lamivudine-resistant patients with a complete virological response after lamivudine and adefovir combination therapy.Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine.Hepatocellular carcinoma surveillance in hepatitis B virus-infected individuals: Who and how?Clinical Application of Vibration Controlled Transient Elastography in Patients with Chronic Hepatitis B.Combination of Transient Elastography and an Enhanced Liver Fibrosis Test to Assess the Degree of Liver Fibrosis in Patients with Chronic Hepatitis B.On-treatment changes of liver stiffness at week 26 could predict 2-year clinical outcomes in HBV-related compensated cirrhosis.Validation of risk prediction models for the development of HBV-related HCC: a retrospective multi-center 10-year follow-up cohort study.The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer.Reply to Boyd and Lacombe.Patients with chronic hepatitis B should be screened for hepatocellular carcinoma regardless of liver stiffness measurement.Usefulness of Enhanced Liver Fibrosis, Glycosylation Isomer of Mac-2 Binding Protein, Galectin-3, and Soluble Suppression of Tumorigenicity 2 for Assessing Liver Fibrosis in Chronic Liver Diseases.Role of two-dimensional shear wave elastography in chronic liver diseases: A narrative review
P2860
Q26771433-8A2A96CF-FE1A-4ABD-B321-3627867B7ACEQ30375738-53C8D3F6-2AF0-4465-9F66-BEEF6AE7ED15Q33787655-A1A0016E-7326-448A-B0F0-4211921548D5Q35992400-79CD898E-BA87-4E8F-9AD6-925FDBED7D58Q36993037-B39E0F61-F797-4A1C-BA80-66896602688BQ37205302-E2DCE9E4-FF5C-49C5-A0FE-85C1E73CC762Q38588078-9C6CE4FA-D1DD-41BC-B5CC-08C02B224809Q38662540-2DB3FFC3-F71A-4CD0-8A26-25271178F58BQ38676705-5420E352-CF68-404D-8554-5DF95F302000Q38689700-D23B8364-A355-4E08-8777-174370C27FCDQ38708562-79C65DAE-0A42-4F6D-A249-CAD4E24659E2Q38948862-FD466E02-7ABB-485D-9EA4-B9D6777A59CEQ40172883-D2787257-0707-4584-A59B-3E053D77E7FFQ40259385-CEC918C6-83C8-462E-9FBF-5EB40168AB20Q40502187-75F4E148-FD9C-41C3-A6AF-AFEE5B9F382CQ41921861-EE99A372-DB7C-4F95-A5A6-F0A93AE125F7Q45341848-09933604-8CFD-4B7A-BB8D-0E4E17E50749Q47101834-F5FEADC1-FF63-49DD-A669-7B6CE1F38591Q47630903-EE0123EE-69AE-4BF3-9ED5-72AC9ADFB9D0Q48049424-E61C6233-F5E0-4379-A04A-9E62AB8FA4B3Q49802355-77556B4F-B8EB-4FFF-B8E2-583DA66827FCQ50350640-741B5991-13A6-4187-855D-B9A2DF7A488BQ50969455-1781D072-32D8-4F27-B8E7-6F8D434103B1Q51016420-D7C8C223-C9AB-4327-BD84-6C9C34CFDEAEQ55353688-5CB87D95-067C-45BE-827D-8FBF3EC5D4FEQ58740380-22130790-8DF2-45BB-8C96-F21BAF78EC18
P2860
Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with transient elastography-defined subclinical cirrhosis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Increased risk of hepatocellul ...... defined subclinical cirrhosis.
@en
Increased risk of hepatocellul ...... defined subclinical cirrhosis.
@nl
type
label
Increased risk of hepatocellul ...... defined subclinical cirrhosis.
@en
Increased risk of hepatocellul ...... defined subclinical cirrhosis.
@nl
prefLabel
Increased risk of hepatocellul ...... defined subclinical cirrhosis.
@en
Increased risk of hepatocellul ...... defined subclinical cirrhosis.
@nl
P2093
P2860
P356
P1433
P1476
Increased risk of hepatocellul ...... defined subclinical cirrhosis.
@en
P2093
Beom Kyung Kim
Do Young Kim
Jun Yong Park
Ki Jun Song
Seung Up Kim
Young Nyun Park
P2860
P304
P356
10.1002/HEP.27735
P407
P577
2015-03-20T00:00:00Z